...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: AACR virtual meeting June22nd
1
May 16, 2020 01:58PM

Thx for correction Bear.Does this mean it is another trial or just lab work in addition to the breast trial?

Share
New Message
Please login to post a reply